Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc fingers and homeoboxes protein 1 (ZHX1) is a nuclear transcriptional repressor encoded by the ZHX1 gene in humans. It is characterized by the presence of two C2H2-type zinc finger motifs and five homeobox DNA-binding domains, enabling it to bind DNA and repress gene transcription. ZHX1 forms homodimers and heterodimers (particularly with ZHX2 and ZHX3), and interacts with transcriptional regulators, including the A subunit of nuclear factor-Y (NF-YA). ZHX1 is predominantly localized in the nucleus and functions as a corepressor, participating in the regulation of cell differentiation—particularly in neural and hematopoietic lineages—and in the specification of cardiac progenitors. Dysregulation or aberrant expression of ZHX1 is associated with multiple diseases, including various cancers and kidney disorders. No therapeutic drugs are known to target ZHX1 directly as of the latest available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc fingers and homeoboxes protein 1 (ZHX1).